SCHEMBL24879342

SCHEMBL24879342

COCC(Cn1cnc2c(N)[nH]c(=O)nc21)OC

nearest known ligand 0.44

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
HPRT1 P00492 18/20 0.44
BLM P54132 2/20 0.41
MEN1 O00255 1/20 0.41
ALDH1A1 P00352 1/20 0.41
LMNA P02545 1/20 0.41
CYP3A4 P08684 1/20 0.41
NFKB1 P19838 1/20 0.41
VCP P55072 1/20 0.41
KMT2A Q03164 1/20 0.41
SMN1; SMN2 Q16637 1/20 0.41
HIF1A Q16665 1/20 0.41
USP2 O75604 1/20 0.40
PNP P00491 1/20 0.40
TSHR P16473 1/20 0.40
EDNRA P25101 1/20 0.40
HTR2A P28223 1/20 0.40
RECQL P46063 1/20 0.40
HBB P68871 1/20 0.40
HSD17B10 Q99714 1/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24264301 0.83 HPRT1 (0.62) HPRT1BLMMEN1ALDH1A1LMNA
SCHEMBL24772407 0.80 HPRT1 (0.43) HPRT1BLMMEN1ALDH1A1LMNA
SCHEMBL13074136 0.76 CDK1 (0.54) HPRT1BLMMEN1ALDH1A1LMNA
SCHEMBL10992496 0.76 BLM (0.70) HPRT1BLMMEN1ALDH1A1LMNA
SCHEMBL23547672 0.74 ADORA2A (0.60) ALDH1A1LMNACYP3A4SMN1; SMN2
SCHEMBL22855519 0.74 ADORA2A (0.60) ALDH1A1LMNACYP3A4SMN1; SMN2
SCHEMBL10076894 0.70 HPRT1 (0.45) HPRT1BLMMEN1ALDH1A1LMNA
SCHEMBL14669070 0.70 HPRT1 (0.71) HPRT1BLMMEN1ALDH1A1LMNA
SCHEMBL14669071 0.70 HPRT1 (0.71) HPRT1BLMMEN1ALDH1A1LMNA
SCHEMBL14669187 0.70 HPRT1 (0.71) HPRT1BLMMEN1ALDH1A1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 6 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2024073709-A2 MODIFIED OLIGONUCLEOTIDES AND DOUBLE-STRANDED RNAS ALNYLAM PHARMACEUTICALS, INC. (US) 2024-04-04 WO disclosed
WO-2024006953-A2 MONOMERS AND METHODS FOR SYNTHESIS OF MODIFIED OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2024-01-04 WO disclosed
WO-2022155418-A9 MODIFIED OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2023-03-09 WO disclosed
WO-2023288047-A2 MULTIPLEXING TARGETING LIGANDS THROUGH CLICK CHEMISTRY AT THE ANOMERIC SITE OF SUGARS ALNYLAM PHARMACEUTICALS, INC. (US) 2023-01-19 WO disclosed
WO-2023288045-A2 SIMPLE CHEMICAL APPROACHES TO INTRODUCE 2,6-DIAMINOPURINE AND 2-AMINOADENINE CONJUGATES INTO OLIGONUCLEOTIDES ALNYLAM PHARMACEUTICALS, INC. (US) 2023-01-19 WO disclosed
WO-2023283434-A1 AMINOOXY CLICK CHEMISTRY (AOCC): A VERSATILE BIOCONJUGATION APPROACH ALNYLAM PHARMACEUTICALS, INC. (US) 2023-01-12 WO disclosed